Home Other Building Blocks 199433-58-4
199433-58-4,MFCD16038858
Catalog No.:AA002C1F

199433-58-4 | Y-33075

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$112.00   $78.00
- +
5mg
≥98%
in stock  
$528.00   $369.00
- +
10mg
≥98%
in stock  
$942.00   $659.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002C1F
Chemical Name:
Y-33075
CAS Number:
199433-58-4
Molecular Formula:
C16H16N4O
Molecular Weight:
280.3244
MDL Number:
MFCD16038858
SMILES:
O=C(c1ccc(cc1)[C@H](N)C)Nc1ccnc2c1cc[nH]2
Properties
Computed Properties
 
Complexity:
367  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
3  
XLogP3:
1.4  

Downstream Synthesis Route

[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION;SENJUPHARMACEUTICALCO.,LTD.-EP1378247,2016,B1

[1]CurrentPatentAssignee:MITSUBISHICHEMICALHOLDINGSCORPORATION;SENJUPHARMACEUTICALCO.,LTD.-EP1378247,2016,B1Locationinpatent:Paragraph0077

Literature

Title: Effects of Y-39983, a selective Rho-associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats.

Journal: Current eye research 20111001

Title: Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries.

Journal: Japanese journal of ophthalmology 20110701

Title: Rho-Rho kinase pathway in the actomyosin contraction and cell-matrix adhesion in immortalized human trabecular meshwork cells.

Journal: Molecular vision 20110101

Title: Benzothiophene containing Rho kinase inhibitors: Efficacy in an animal model of glaucoma.

Journal: Bioorganic & medicinal chemistry letters 20100601

Title: Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma.

Journal: Journal of medicinal chemistry 20091112

Title: Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090601

Title: [Optic nerve regeneration in adult mammals].

Journal: Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20080601

Title: A novel ROCK inhibitor, Y-39983, promotes regeneration of crushed axons of retinal ganglion cells into the optic nerve of adult cats.

Journal: Experimental neurology 20070501

Title: Hideki Tokushige, et al. Effects of Topical Administration of Y-39983, a Selective Rho-Associated Protein Kinase Inhibitor, on Ocular Tissues in Rabbits and Monkeys Invest. Ophthalmol. Vis. Sci. July 2007 vol. 48no. 7 3216-3222

Title: Tokushige H, et al. Effects of Y-39983, a selective Rho-associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats. Curr Eye Res. 2011 Oct;36(10):964-70.

Title: Watabe H, et al. Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries.Jpn J Ophthalmol. 2011 Jul;55(4):411-7. Epub 2011 Jun 11.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:199433-58-4 Molecular Formula|199433-58-4 MDL|199433-58-4 SMILES|199433-58-4 Y-33075